Previous 10 | Next 10 |
IRVINE, Calif. , April 23, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended March 31, 2019. ...
Edwards Lifesciences (NYSE: EW ) is scheduled to announce Q1 earnings results on Tuesday, April 23rd, after market close. The consensus EPS Estimate is $1.22 (flat Y/Y) and the consensus Revenue Estimate is $989.87M (+5.6% Y/Y). Over the last 2 years, ew has beaten EPS estimates 75% ...
AMTD , BXMT , CHFC , CP , CSGP , CSL , EBAY , EW , FCPT , FE , FMBI , FR , HA , HIW , HXL , IRBT , KALU , LRN , LTXB , MANH , MMSI , MTH , NAVI , NBHC , NWE , RHI , RNST , SITC , SIX , SNAP , SPN , SYK , TER , TRMK , TSS , TXN , UCBI , VMI , WRB Fo...
Merger activity increased last week with five new deals announced and six pending deals closing. Deal Statistics: New Deals: The acquisition of Advanced Disposal Services (ADSW) by Waste Management (WM) for $4.9 billion or $33.15 per share in cash. The acquisition of Electro...
IRVINE, Calif. , April 18, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced the completion of its acquisition of CAS Medical Systems, Inc. (NAS...
Yes, it shrinks As you know, healthcare stocks and ETFs, such as the Health Care Select SPDR ETF ( XLV ), have gotten slammed following additional publicity given just a few days ago to Senator Bernie Sanders and his "Medicare for all" ((MFA)) program. Before the political season began this ...
Neovasc (NASDAQ: NVCN ) has agreed to settle the remaining litigation with Edwards Lifesciences (NYSE: EW ) over three patents covering CardiAQ, adding two CardiAQ employees as co-inventors, the same remedy that was agreed to regarding an earlier patent. More news on: Neovasc Inc., Edwar...
This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages. Executive summary Biotechnology looks significantly underpriced relative to historical averages combi...
IRVINE, Calif. , April 9, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended March 31, 2019 after the ...
Quick Take Silk Road Medical ( SILK ) intends to raise $75 million in an IPO of its common stock, per an amended registration statement . The company sells a transcarotid artery stenting device in the U.S. SILK is growing rapidly in the U.S., has strong growth prospects internationally ...
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Vancouver, British Columbia--(Newsfile Corp. - July 30, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to provide this update in regard to the status of the proposed return of capital announced on June 19, 2024 . The Company has prepared and mailed its ...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 1.7% to $112.28 on volume of 455,296,152 shares Ford Motor Company (F) fell 18.4% to $11.16 on volume of 256,384,806 shares PROSHARES TRUST (SQQQ) rose 3.4% to $9.37 on volume of 246,885,889 shares Sel...
2024-07-25 16:00:08 ET Pito Chickering from Deutsche Bank issued a price target of $85.00 for EW on 2024-07-25 13:36:00. The adjusted price target was set to $85.00. At the time of the announcement, EW was trading at $60.58. The overall price target consensus is at $109....